Literature DB >> 12678715

Phage display selection and evaluation of cancer drug targets.

Victor I Romanov1.   

Abstract

Techniques for the construction of phage display libraries of combinatorial proteins have dramatically improved. This has allowed researchers to expand the applications to the field of cancer biology. The most direct use of protein phage-displayed libraries is the selection of ligands for individual proteins. This includes identification of peptide ligands for receptor signaling molecules: integrins, cytokine and growth factor receptors. Selected peptides may be used as competitors for natural ligands and for the mapping of binding epitopes. This approach has been exploited for delineation of intracellular signal transduction pathways and for the selection of enzyme substrates and inhibitors. Recently, more complicated biological systems were used as targets for biopanning. This includes combination of soluble proteins, cellular surfaces and even the vasculature of whole organs. cDNA expression libraries in phage-based vectors have been recently introduced. The use of phage as a vector for targeted gene therapy is also considered. These and other applications of phage display for cancer research will be reviewed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12678715     DOI: 10.2174/1568009033482010

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  6 in total

1.  Human scFv antibody fragments specific for hepatocellular carcinoma selected from a phage display library.

Authors:  Bing Yu; Ming Ni; Wen-Han Li; Ping Lei; Wei Xing; Dai-Wen Xiao; Yu Huang; Zhen-Jie Tang; Hui-Fen Zhu; Guan-Xin Shen
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

2.  Liposomes targeted by fusion phage proteins.

Authors:  Prashanth K Jayanna; Vladimir P Torchilin; Valery A Petrenko
Journal:  Nanomedicine       Date:  2008-10-01       Impact factor: 5.307

Review 3.  Phage protein-targeted cancer nanomedicines.

Authors:  V A Petrenko; P K Jayanna
Journal:  FEBS Lett       Date:  2013-11-20       Impact factor: 4.124

Review 4.  Display technologies: application for the discovery of drug and gene delivery agents.

Authors:  Anna Sergeeva; Mikhail G Kolonin; Jeffrey J Molldrem; Renata Pasqualini; Wadih Arap
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

5.  B1.12: a novel peptide interacting with the extracellular loop of the EBV oncoprotein LMP1.

Authors:  Nihel Ammous-Boukhris; Amor Mosbah; Wajdi Ayadi; Emna Sahli; Soizic Chevance; Arnaud Bondon; Ali Gargouri; Michele Baudy-Floc'h; Raja Mokdad-Gargouri
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

6.  The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs.

Authors:  Lauren R H Krumpe; Toshiyuki Mori
Journal:  Int J Pept Res Ther       Date:  2006-03-03       Impact factor: 1.931

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.